H. Heffernan

发表

The changing landscape of antimicrobial resistance in New Zealand.

D. Williamson, H. Heffernan, 2014, The New Zealand medical journal.

Rectal colonization with New Delhi metallo-β-lactamase-1-producing Escherichia coli prior to transrectal ultrasound (TRUS)-guided prostate biopsy.

D. Paterson, J. Masters, D. Williamson, 2013, The Journal of antimicrobial chemotherapy.

Contemporary genomic approaches in the diagnosis and typing of Staphylococcus aureus

D. Williamson, G. Nimmo, H. Heffernan, 2015, Pathology.

High rates of susceptibility to ceftazidime among globally prevalent CTX-M-producing Escherichia coli: potential clinical implications of the revised CLSI interpretive criteria

S. Roberts, D. Williamson, H. Heffernan, 2011, European Journal of Clinical Microbiology & Infectious Diseases.

First cases of KPC-type carbapenemase-producing bacteria in patients in New Zealand hospitals.

Susan L. Taylor, H. Heffernan, K. Dyet, 2014, Journal of global antimicrobial resistance.

Salmonella enterica serotypes and antibiotic susceptibility in New Zealand, 2002–2007

E. Broughton, H. Heffernan, C. Coles, 2009, Epidemiology and Infection.

Annual survey of methicillin-resistant Staphylococcus aureus (MRSA), 2010

H. Heffernan, Erin L. Higgins, A. Richardson, 2010 .

ANTIMICROBIAL SUSCEPTIBILITY OF GROUP A STREPTOCOCCI IN NEW ZEALAND IN 2001 by

H. Heffernan, R. Stanley, 2004 .

2017 survey of methicillin-resistant Staphylococcus aureus (MRSA)

H. Heffernan, S. Bakker, 2018 .

Comparative epidemiology of CTX-M-14 and CTX-M-15 producing Escherichia coli: Association with distinct demographic groups in the community in New Zealand

S. Roberts, D. Williamson, S. Roberts, 2012, European Journal of Clinical Microbiology & Infectious Diseases.

Vancomycin-resistant enterococci remain rare in New Zealand

H. Heffernan, T. Blackmore, 2003 .

Phenotypic and molecular characterization of community occurring, Western Samoan phage pattern methicillin-resistant Staphylococcus aureus.

G. Cook, I. Lamont, R. Adhikari, 2002, The Journal of antimicrobial chemotherapy.

Antimicrobial susceptibility among Neisseria gonorrhoeae in New Zealand in 2002.

M. Brokenshire, H. Heffernan, T. Blackmore, 2004, The New Zealand medical journal.

Severe Clostridium difficile infection in New Zealand associated with an emerging strain, PCR-ribotype 244.

T. Riley, Susan L. Taylor, S. Roberts, 2013, The New Zealand medical journal.

Mupirocin and Staphylococcus aureus: a recent paradigm of emerging antibiotic resistance.

A. Upton, H. Heffernan, S. Lang, 2003, The Journal of antimicrobial chemotherapy.

Evolution and Global Transmission of a Multidrug-Resistant, Community-Associated Methicillin-Resistant Staphylococcus aureus Lineage from the Indian Subcontinent

J. Parkhill, S. Bentley, S. Harris, 2019, mBio.

Global phylogenomics of multidrug-resistant Staphylococcus aureus sequence type 772: the Bengal Bay clone

J. Parkhill, S. Bentley, S. Harris, 2017, bioRxiv.

A phylogenomic framework for assessing the global emergence and evolution of clonal complex 398 methicillin-resistant Staphylococcus aureus

N. French, J. Kwong, D. Bulach, 2017, Microbial genomics.

Methicillin-resistant Staphylococcus aureus, Samoa, 2007-2008.

P. Herbison, P. Norris, S. Ritchie, 2011, Emerging infectious diseases.

Activity of iclaprim against Legionella pneumophila

A. Upton, Susan L. Taylor, H. Heffernan, 2007 .

Methicillin-Resistant Staphylococcus aureus, Samoa, 2007–2008

P. Herbison, P. Norris, S. Ritchie, 2011, Emerging Infectious Diseases.

Variation in erythromycin and clindamycin resistance patterns between New Zealand and Australian group B streptococcus isolates

V. Clifford, K. Grimwood, S. Garland, 2011, The Australian & New Zealand journal of obstetrics & gynaecology.

Invasive pneumococcal disease in New Zealand 1998–2005: capsular serotypes and antimicrobial resistance

J. Morgan, H. Heffernan, T. Blackmore, 2007, Epidemiology and Infection.

Outcomes of adults with invasive meningococcal disease with reduced penicillin susceptibility in Auckland 2004–2017

S. Svensson, Mark Thomas, R. Webb, 2022, Infection.

High usage of topical fusidic acid and rapid clonal expansion of fusidic acid-resistant Staphylococcus aureus: a cautionary tale.

S. Monecke, A. Upton, J. Fraser, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Successful intervention in a group A meningococcal outbreak in Auckland, New Zealand.

B. Gellin, D. Lennon, H. Heffernan, 1992, The Pediatric infectious disease journal.

ANTIMICROBIAL RESISTANCE AMONG GRAM-NEGATIVE BACILLI FROM BACTERAEMIA , 2007

H. Heffernan, R. Woodhouse, 2009 .

TUBERCULOSIS IN NEW ZEALAND ANNUAL REPORT 2010

E. Lim, A. Bissielo, H. Heffernan, 2011 .

Plasmid-mediated AmpC beta-lactamase-producing Escherichia coli causing urinary tract infection in the Auckland community likely to be resistant to commonly prescribed antimicrobials.

A. Morris, H. Heffernan, K. Dyet, 2015, The New Zealand medical journal.

Antibiotic resistance among salmonella from human and other sources in New Zealand

H. Heffernan, 1991, Epidemiology and Infection.

Emergence and molecular characterization of clonal complex 398 (CC398) methicillin-resistant Staphylococcus aureus (MRSA) in New Zealand.

S. Monecke, D. Williamson, H. Heffernan, 2014, The Journal of antimicrobial chemotherapy.

Community-Acquired Methicillin-Resistant Staphylococcus aureus Carrying Panton-Valentine Leukocidin Genes: Worldwide Emergence

F. Vandenesch, G. Lina, T. Naimi, 2003, Emerging infectious diseases.

Prevalence and types of extended-spectrum beta-lactamases among urinary Escherichia coli and Klebsiella spp. in New Zealand.

C. Pope, H. Heffernan, T. Blackmore, 2009, International journal of antimicrobial agents.

The clear and present danger of carbapenemase-producing Enterobacteriaceae (CPE) in New Zealand: time for a national response plan.

S. Roberts, H. Heffernan, J. Freeman, 2017, The New Zealand medical journal.

Salmonella serotypes isolated from pet chews in New Zealand

H. Heffernan, T. Wong, K. Thom, 2007, Journal of applied microbiology.

Two compatibility groups among coII plasmids.

H. Heffernan, S. Howarth-Thompson, M. D. Buchan, 1974, Journal of general microbiology.

Evolution and Global Transmission of a Multidrug-Resistant, Community-Associated Methicillin-Resistant Staphylococcus aureus Lineage from the Indian Subcontinent

J. Parkhill, S. Bentley, S. Harris, 2019 .

Emergence and global spread of a multidrug-resistant, community-associated MRSA lineage from the Indian subcontinent

J. Parkhill, S. Bentley, S. Harris, 2018 .

IDENTIFICATION OF EXTENDED-SPECTRUM β-LACTAMASE TYPES, PLASMID-MEDIATED AMPC β-LACTAMASES AND STRAINS AMONG URINARY ESCHERICHIA COLI AND KLEBSIELLA IN NEW ZEALAND IN 2006

P. Carter, C. Pope, H. Heffernan, 2007 .

Comparative epidemiology of CTX-M-14 and CTX-M-15 producing Escherichia coli: Association with distinct demographic groups in the community in New Zealand

S. Roberts, D. Williamson, H. Heffernan, 2012, European Journal of Clinical Microbiology & Infectious Diseases.

CMY-29 and CMY-30, Two Novel Plasmid-Mediated AmpC β-Lactamases

P. Carter, C. Pope, H. Heffernan, 2009, Antimicrobial Agents and Chemotherapy.

Extended-spectrum beta-lactamase (ESBL)-producing enterobacteria: factors associated with infection in the community setting, Auckland, New Zealand.

G. Simmons, A. Morris, S. Roberts, 2008, The Journal of hospital infection.

High prevalence of CTX-M-15 extended-spectrum beta-lactamase among contacts of patients with shigellosis due to Shigella flexneri carrying CTX-M-15.

A. Upton, G. Simmons, H. Heffernan, 2007, The Journal of antimicrobial chemotherapy.

EXTENDED-SPECTRUM β-LACTAMASES AMONG URINARY ESCHERICHIA COLI AND KLEBSIELLA IN NEW ZEALAND IN 2006

H. Heffernan, T. Blackmore, R. Woodhouse, 2006 .

Isolation of seven distinct carbapenemase-producing Gram-negative organisms from a single patient

H. Heffernan, J. Creighton, J. Howard, 2017, The Journal of antimicrobial chemotherapy.

Antibiotic susceptibilities, serotypes and auxotypes of Neisseria gonorrhoeae isolated in New Zealand.

H. Heffernan, M. Brett, H. Davies, 1992, Genitourinary medicine.

Topical Antibiotic Use Coselects for the Carriage of Mobile Genetic Elements Conferring Resistance to Unrelated Antimicrobials in Staphylococcus aureus

Mark B. Schultz, G. Carter, T. Stinear, 2017, Antimicrobial Agents and Chemotherapy.

An outbreak of meningococcal disease in Auckland, New Zealand.

D. Lennon, H. Heffernan, L. Voss, 1989, The Pediatric infectious disease journal.

Rapid Emergence and Evolution of Staphylococcus aureus Clones Harboring fusC-Containing Staphylococcal Cassette Chromosome Elements

J. Kwong, G. Carter, T. Seemann, 2016, Antimicrobial Agents and Chemotherapy.

Epidemic strains of Clostridium difficile are present in Auckland, New Zealand.

S. Roberts, D. Williamson, H. Heffernan, 2011, The New Zealand medical journal.

Community-onset genitourinary tract infection due to CTX-M-15-Producing Escherichia coli among travelers to the Indian subcontinent in New Zealand.

S. McBride, H. Heffernan, J. Freeman, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Genomic epidemiology and antimicrobial resistance of Neisseria gonorrhoeae in New Zealand

J. Kwong, D. Bulach, G. Carter, 2017, The Journal of antimicrobial chemotherapy.

Neonatal invasive pneumococcal disease: New Zealand experience in the era of pneumococcal vaccination

V. Mount, H. Heffernan, E. Best, 2017, The Australian & New Zealand journal of obstetrics & gynaecology.

Genomic Analysis of Multiresistant Staphylococcus capitis Associated with Neonatal Sepsis

Anders Gonçalves da Silva, T. Riley, G. Carter, 2018, Antimicrobial Agents and Chemotherapy.

Vancomycin-resistant Enterococcus faecium sequence type 796 - rapid international dissemination of a new epidemic clone

A. Cheng, J. Ferguson, T. Seemann, 2018, Antimicrobial Resistance & Infection Control.

Pediatric Invasive Meningococcal Disease, Auckland, New Zealand (Aotearoa), 2004–2020

R. Webb, H. Heffernan, E. Best, 2023, Emerging infectious diseases.

Clinical and Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus in New Zealand: Rapid Emergence of Sequence Type 5 (ST5)-SCCmec-IV as the Dominant Community-Associated MRSA Clone

J. Fraser, D. Williamson, S. Roberts, 2013, PloS one.

Outcomes of adults with invasive meningococcal disease with reduced penicillin susceptibility in Auckland 2004–2017

S. Svensson, Mark Thomas, R. Webb, 2022, Infection.

Identification and molecular characterisation of New Delhi metallo-β-lactamase-1 (NDM-1)- and NDM-6-producing Enterobacteriaceae from New Zealand hospitals.

D. Paterson, D. Williamson, H. Sidjabat, 2012, International journal of antimicrobial agents.

High rates of susceptibility to ceftazidime among globally prevalent CTX-M-producing Escherichia coli: potential clinical implications of the revised CLSI interpretive criteria

S. Roberts, D. Williamson, H. Heffernan, 2012, European Journal of Clinical Microbiology & Infectious Diseases.

Evidence of transmission of an NDM-5-producing Klebsiella pneumoniae in a healthcare facility in New Zealand

H. Heffernan, J. Creighton, A. Werno, 2016, The Journal of antimicrobial chemotherapy.

Global Scale Dissemination of ST93: A Divergent Staphylococcus aureus Epidemic Lineage That Has Recently Emerged From Remote Northern Australia

J. Parkhill, S. Bentley, S. Harris, 2018, Front. Microbiol..

Vancomycin-resistant Enterococcus faecium sequence type 796 - rapid international dissemination of a new epidemic clone

A. Cheng, J. Ferguson, T. Seemann, 2018, Antimicrobial Resistance and Infection Control.

Intercontinental transfer of OXA-181-producing Klebsiella pneumoniae into New Zealand.

D. Paterson, D. Williamson, H. Sidjabat, 2011, The Journal of antimicrobial chemotherapy.

Evolution and global transmission of a multidrug-resistant , community-1 associated MRSA lineage from the Indian subcontinent 2 3

J. Parkhill, S. Bentley, S. Harris, 2019 .

Materials and Methods Bacterial Strains Community-acquired Methicillin- Resistant Staphylococcus Aureus Carrying Panton-valentine Leukocidin Genes: Worldwide Emergence

F. Vandenesch, G. Lina, T. Naimi, 2022 .